Zyprexa-discuss -- Discussion of Eli Lilly's drug Zyprexa
About Zyprexa-discuss	English (USA)
Zyprexa is a trademark of Eli Lilly for the drug Olanzapine. Recently some New York Times articles emerged with the claim that Eli Lilly suppressed information about the drug's safety. We do not want the list archives to contain copyright-violating materials. We will discuss anything you want so long as you stick to this rule; you can link to whatever you want, just don't attach it. This list is for discussing the drug's safety and how we can learn more about it. We're interested in more information and second opinions. To see the collection of prior postings to the list, visit the Zyprexa-discuss Archives.
Using Zyprexa-discuss
To post a message to all the list members, send email to zyprexa-discuss@acm.jhu.edu. You can subscribe to the list, or change your existing subscription, in the sections below.
Subscribing to Zyprexa-discuss
Subscribe to Zyprexa-discuss by filling out the following form. You will be sent email requesting confirmation, to prevent others from gratuitously subscribing you. This is a private list, which means that the list of members is not available to non-members. Your email address:   Your name (optional):   Which language do you prefer to display your messages? English (USA)   Would you like to receive list mail batched in a daily digest? No Yes
Zyprexa-discuss Subscribers
(The subscribers list is only available to the list members.) Enter your address and password to visit the subscribers list: Address: Password:    To unsubscribe from Zyprexa-discuss, get a password reminder, or change your subscription options enter your subscription email address: If you leave the field blank, you will be prompted for your email address